Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11496
Title: Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer.
Authors: John, Thomas;Yanagawa, Naoki;Kohler, Derek;Craddock, Kenneth J;Bandarchi-Chamkhaleh, Bizhan;Pintilie, Melania;Sykes, Jenna;To, Christine;Li, Ming;Panchal, Devang;Chen, Weisan;Shepherd, Frances A;Tsao, Ming-Sound
Affiliation: Ludwig Institute for Cancer Research, Austin Health, Melbourne, Australia. tom.john@ludwig.edu.au
Issue Date: 1-Jul-2012
Citation: Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer; 7(7): 1101-8
Abstract: Xenograft models of epithelial malignancies potentially have greater correlation with clinical end points. We implanted 153 primary non-small cell lung carcinomas into non-obese diabetic-severe combined immunodeficient mice to develop primary lung cancer xenografts. Sixty-three xenografts formed. However, in 19 implantations, tumors consisted of a lymphocyte proliferation without a carcinoma component. We further characterized these lymphomas to determine clinicopathological features associated with their formation.Lymphomas were investigated morphologically and by silver in situ hybridization to determine their species of origin. Characterization both of the xenograft lymphomas and the primary NSCLCs from which they were derived included immunohistochemistry for lymphoma markers and Epstein Barr virus Early RNA (EBER) by in situ hybridization. DNA was profiled using the MassARRAY platform; EML4-ALK translocations and lymphocyte infiltration were assessed in the primary tumor. Lymphoma formation was correlated with patient and primary tumor characteristics and survival.The lymphocytic tumors were EBER positive, human diffuse large B-cell lymphomas (DLBCLs). Significantly more DLBCLs that formed in mice arose in primary lung adenocarcinomas and in epithelial growth factor receptor mutant never smokers. DLBCL formation was not associated with the degree of tumor-infiltrating lymphocytes or EBER-positive lymphocytes in the primary NSCLCs. Patients whose tumors developed DLBCL had longer disease-free survival compared with patients whose tumors formed epithelial xenografts (hazard ratio: 0.44; 95% confidence interval: 0.18 -1.06, Wald p = 0.07), regardless of genotype.We hypothesize that mechanisms involved in the active suppression of viral antigens may also be involved in the suppression of tumor antigens, and may have resulted in the observed favorable clinical outcome.
Internal ID Number: 22617243
URI: http://ahro.austin.org.au/austinjspui/handle/1/11496
DOI: 10.1097/JTO.0b013e3182519d4d
URL: http://www.ncbi.nlm.nih.gov/pubmed/22617243
Type: Journal Article
Subjects: Adenocarcinoma.complications.mortality.virology
Adult
Aged
Aged, 80 and over
Animals
Antigens, Viral.immunology.metabolism
Carcinoma, Non-Small-Cell Lung.complications.mortality.virology
Carcinoma, Squamous Cell.complications.mortality.virology
Epstein-Barr Virus Infections.complications
Female
Gene Rearrangement
Herpesvirus 4, Human.genetics.pathogenicity
Humans
Immunoenzyme Techniques
Immunophenotyping
In Situ Hybridization
Lung Neoplasms.complications.mortality.virology
Lymphocytes, Tumor-Infiltrating.immunology.pathology
Lymphoma, Large B-Cell, Diffuse.etiology.mortality
Male
Mice
Mice, SCID
Middle Aged
Mutation.genetics
Neoplasm Staging
Oncogene Proteins, Fusion.genetics
Polymerase Chain Reaction
Prognosis
RNA, Viral.genetics
Survival Rate
Transplantation, Heterologous
Tumor Markers, Biological.metabolism
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.